BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33632256)

  • 1. Clinicopathologic characteristics, metastasis-free survival, and skeletal-related events in 628 patients with skeletal metastases in a tertiary orthopedic and trauma center.
    Herget G; Saravi B; Schwarzkopf E; Wigand M; Südkamp N; Schmal H; Uhl M; Lang G
    World J Surg Oncol; 2021 Feb; 19(1):62. PubMed ID: 33632256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
    McDougall JA; Bansal A; Goulart BH; McCune JS; Karnopp A; Fedorenko C; Greenlee S; Valderrama A; Sullivan SD; Ramsey SD
    Oncologist; 2016 Mar; 21(3):320-6. PubMed ID: 26865591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
    Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Tablazon IL; Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Freedland SJ; Williams SB
    Cancer; 2019 Nov; 125(22):4003-4010. PubMed ID: 31390061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.
    Cetin K; Christiansen CF; Jacobsen JB; Nørgaard M; Sørensen HT
    Lung Cancer; 2014 Nov; 86(2):247-54. PubMed ID: 25240518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.
    Jensen AØ; Jacobsen JB; Nørgaard M; Yong M; Fryzek JP; Sørensen HT
    BMC Cancer; 2011 Jan; 11():29. PubMed ID: 21261987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer.
    da Silva GT; Bergmann A; Thuler LCS
    Support Care Cancer; 2016 Feb; 24(2):731-736. PubMed ID: 26143039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
    Tsuda Y; Nakagawa T; Shinoda Y; Kanatani A; Kawai T; Taguchi S; Yamada Y; Sawada R; Kume H; Homma Y; Tanaka S; Kawano H
    Int J Clin Oncol; 2017 Jun; 22(3):548-553. PubMed ID: 28044212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.
    Harding JJ; Abu-Zeinah G; Chou JF; Owen DH; Ly M; Lowery MA; Capanu M; Do R; Kemeny NE; O'Reilly EM; Saltz LB; Abou-Alfa GK
    J Natl Compr Canc Netw; 2018 Jan; 16(1):50-58. PubMed ID: 29295881
    [No Abstract]   [Full Text] [Related]  

  • 11. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
    Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
    Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between lung cancer histology and the clinicopathological characteristics of bone metastases.
    Oliveira MB; Mello FC; Paschoal ME
    Lung Cancer; 2016 Jun; 96():19-24. PubMed ID: 27133744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan.
    Yamashiro H; Takada M; Nakatani E; Imai S; Yamauchi A; Tsuyuki S; Matsutani Y; Sakata S; Wada Y; Okamura R; Harada T; Tanaka F; Moriguchi Y; Kato H; Higashide S; Kan N; Yoshibayashi H; Suwa H; Okino T; Nakayama I; Ichinose Y; Yamagami K; Hashimoto T; Inamoto T; Toi M
    Int J Clin Oncol; 2014 Oct; 19(5):852-62. PubMed ID: 24292334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
    Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
    PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and skeletal-related events in patients with bone metastasis from gastric cancer.
    Imura Y; Tateiwa D; Sugimoto N; Inoue A; Wakamatsu T; Outani H; Tanaka T; Tamiya H; Yagi T; Naka N; Okawa S; Tabuchi T; Takenaka S
    Mol Clin Oncol; 2020 Oct; 13(4):31. PubMed ID: 32765878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.
    Xu JY; Murphy WA; Milton DR; Jimenez C; Rao SN; Habra MA; Waguespack SG; Dadu R; Gagel RF; Ying AK; Cabanillas ME; Weitzman SP; Busaidy NL; Sellin RV; Grubbs E; Sherman SI; Hu MI
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4871-4877. PubMed ID: 27662441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
    Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Divers CH; Valderrama A; Freedland SJ
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):380-384. PubMed ID: 27377207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
    Tanaka R; Yonemori K; Hirakawa A; Kinoshita F; Takahashi N; Hashimoto J; Kodaira M; Yamamoto H; Yunokawa M; Shimizu C; Fujimoto M; Fujiwara Y; Tamura K
    Oncologist; 2016 Apr; 21(4):508-13. PubMed ID: 26975863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone metastases and skeletal-related events: incidence and prognosis according to histological subtype of lung cancer.
    Silva GT; Silva LM; Bergmann A; Thuler LC
    Future Oncol; 2019 Feb; 15(5):485-494. PubMed ID: 30624078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First prospective data on breast cancer patients from the multicentre italian bone metastasis database.
    Bongiovanni A; Foca F; Fantini M; Forcignanò MR; Artioli F; Berardi R; Campadelli E; Procopio G; Silvestris F; Riva N; Gurrieri L; Debonis SA; Di Menna G; Fausti V; Recine F; Vespignani R; Ibrahim T
    Sci Rep; 2021 Feb; 11(1):4329. PubMed ID: 33619285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.